LiveGMP
LiveGMP
The Grey Market Premium for this IPO is currently showing steady interest.
Cautious approach recommended for retail investors.
Details about PharmEasy are not yet available.
Investors looking at the PharmEasy IPO are closely monitoring the Grey Market Premium (GMP) to gauge potential listing gains. Being a Mainboard IPO, PharmEasy has attracted significant attention from both retail and institutional investors.
On this page, we provide real-time updates for PharmEasy GMP, live subscription status, and day-wise premium history. Our goal is to help you decide whether to apply for PharmEasy IPO based on fundamentals, market sentiment, and AI-powered analysis.
Track how many times PharmEasy is subscribed across Retail, HNI, and QIB categories. High subscription often leads to higher GMP and listing gains.
Based on the current GMP of PharmEasy, calculate your potential profit per lot. Remember, GMP is indicative and the actual listing price may vary.
Always check the RHP (Red Herring Prospectus) of PharmEasy on the SEBI website for officially audited financials and risk factors before investing.
How to check PharmEasy IPO Allotment Status?
You can check the allotment status for PharmEasy on our Allotment Page once the registrar finalizes the basis of allotment.
What is the lot size for PharmEasy?
The lot size and price band for PharmEasy are available in the overview table above. Typically, one lot for a Mainboard IPO costs between ₹14,000 to ₹15,000 for retail investors.